Lecturer: Prof. Lieven Annemans, Ghent University, Belgium
2days - 4 hours each
LEARNING OBJECTIVES
At the end of this 2-days module, participants will
• Understand how payers assess technologies depending on their own incentives and setting;
• See the opportunities in changing payment systems for hospitals and clinicians;
• Have insights into the weaknesses of the QALY and the opportunities of disease specific outcome measures;
• Understand the need for a tailored yet coherent value story
• See the options about how to deal via agreements with uncertain evidence
• Understand why health economic evaluations need to start early in the development of medicines/health technologies
• Understand the need to align strategies across functional teams for successful market and patient access of new health technologies
• Have insights in how the development program can anticipate on value - based strategies and access
• Be happy that they have participated at this module
Agenda: https://vscr.at/wp-content/uploads/HTA-Webinar-March_2022_Agenda_080222b.pdf
Apply now: https://vscr.at/public-health/registration-for-module-ii/